239 related articles for article (PubMed ID: 33713159)
1. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
Kuang Y; Li R; Jia P; Ye W; Zhou R; Zhu R; Wang J; Lin S; Pang P; Ji W
Abdom Radiol (NY); 2021 Aug; 46(8):3772-3789. PubMed ID: 33713159
[TBL] [Abstract][Full Text] [Related]
2. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
3. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
4. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
[TBL] [Abstract][Full Text] [Related]
5. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.
Liu Y; Liu Z; Li X; Zhou W; Lin L; Chen X
Acta Radiol; 2024 Jun; 65(6):535-545. PubMed ID: 38489805
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract][Full Text] [Related]
8. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
10. Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study.
Liu QP; Yang KL; Xu X; Liu XS; Qu JR; Zhang YD
Abdom Radiol (NY); 2022 Feb; 47(2):651-663. PubMed ID: 34918174
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
12. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
[TBL] [Abstract][Full Text] [Related]
13. Radiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.
Pan J; Zhang K; Le H; Jiang Y; Li W; Geng Y; Li S; Hong G
J Magn Reson Imaging; 2021 Oct; 54(4):1314-1323. PubMed ID: 33949727
[TBL] [Abstract][Full Text] [Related]
14. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology].
Weng W; Lü XL; Zhang QQ; Zhao XM; Chen CM; Kong CL; Lu CY; Chen MJ; Ji JS
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):828-832. PubMed ID: 32234153
[No Abstract] [Full Text] [Related]
15. Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma.
Fan XL; Wang YH; Chen YH; Chen BX; Cai JN; Yang JS; Sun X; Yan FR; He BS
Abdom Radiol (NY); 2023 Jun; 48(6):2008-2018. PubMed ID: 36943423
[TBL] [Abstract][Full Text] [Related]
16. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
[TBL] [Abstract][Full Text] [Related]
20. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
